Related Experiment Video

Updated: Jun 20, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Prognostic biomarkers in individuals with prevalent coronary heart disease

Sharif A Halim1, L Kristin Newby

  • 1Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715-7969, USA.

Disease Markers
|September 24, 2009
PubMed

Insights

Coronary heart disease is a major global health issue. Identifying patients at risk for future cardiac events is crucial for personalized cardiovascular care and secondary prevention strategies.

Area of Science:

  • Cardiology
  • Biomarkers
  • Personalized Medicine

Background:

  • Coronary heart disease is the leading cause of death globally and a significant healthcare expense.
  • Over 6 million deaths annually are attributed to ischemic heart disease worldwide.
  • In the US, nearly 17 million individuals have coronary heart disease, with 8 million having experienced a myocardial infarction.

Purpose of the Study:

  • To highlight the critical need for identifying patients with coronary disease who are at high risk for future ischemic events.
  • To emphasize the role of biomarkers in risk stratification for personalized cardiovascular care.
  • To discuss the importance of secondary prevention strategies in managing coronary artery disease.

Main Methods:

  • The abstract discusses the general role of biomarkers in risk stratification.
  • It emphasizes the clinical significance of predicting future cardiac events in patients with known coronary artery disease.
  • No specific experimental methods are detailed in this abstract.

Main Results:

  • Patients with known coronary artery disease are at high risk for future cardiac events.
  • Not all patients with coronary disease will experience a recurrent ischemic event.
  • Biomarkers are increasingly important for risk stratification.

Conclusions:

  • Accurate risk stratification is essential for personalized cardiovascular care.
  • Biomarkers will play a critical role in identifying high-risk patients.
  • Effective secondary prevention relies on identifying individuals likely to experience future cardiac events.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...